The FDAnews Webinar Training Pass program offers year-round, unrestricted access to any of the hundreds of webinars listed below. These training programs feature thought leadership and best practices from top consultants, expert speakers and current and former FDA officials. New webinars are offered every month, along with access to the Webinar Training Pass archive.
BUY NOW Single-User 1-Year Unlimited Access $1,362
If you are already a Training Pass member, login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video, click the "Download Presentation" link.
Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Russ Titsch, Business Development Director at russ.titsch@wcgclinical.com or +1 703.538.7651 to receive a custom quote.
Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.
If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.
Webinar Training Pass
Recorded on: Oct. 31, 2017
Description: Regulatory expert David Rosen discusses how principal investigators and sponsors can develop a strategy for dealing with FDA inspections. He covers:
- How BIMO inspections are started and conducted;
- What the BIMO team is looking for in terms of following proper protocols for patient recruitment;
- FDA-recommended best practices in execution of consent forms; and
- Whether patient volunteers are actually eligible participants in a clinical trial.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: David Rosen, Partner, Foley & Lardner LLP
Recorded on: Oct. 30, 2017
Description: Quality assurance expert Susan Leister outlines the risk management requirements in the latest revision of ICH E6 – Good Clinical Practice. She discusses:
- Specific challenge areas: sponsor quality management system, software validation, risk management;
- The hidden implications of certain changes; and
- How to achieve full and effective compliance.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Susan Leister, Director of Quality Assurance, Technical Resources International
Recorded on: Oct. 27, 2017
Description: Supplier contract specialist Courtney Stevens walks you through the essentials of supply contracts. She covers:
- How to approach a contract negotiation;
- What every contract must include;
- Insurance clauses and certificates of insurance; and
- Audit provisions for further protection.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Courtney Stevens, Senior Attorney-Risk Management and Loss Control, MedMarc Insurance Group
Recorded on: Oct. 25, 2017
Description: A panel of digital innovation experts discusses the potential benefits and pitfalls of leveraging connected devices to respond to the changing healthcare industry. They cover:
- How the medical device industry can apply IoMT and outcome-based models to achieve patient well-care;
- What medical device companies are already doing to compete in a new ecosystem that includes at-home patient monitoring;
- How integrated technology solutions close the loop from ideation through postmarket surveillance; and
- How cybersecurity threats are being mitigated.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Sandra Rodriguez, Market Analyst, Axendia; Jordan Reynolds, Senior Manager, Kalypso; David Wolf, Senior Manager, Kalypso
Recorded on: Oct. 24, 2017
Description: Organizer and chair of the 2017 Expanded Access Drug Summit Jess Rabourn explains the new proposed best practices for integrating cohort Expanded Access into the drug development process. He discusses:
- Preapproval access requirements, including key provisions on cost recovery;
- Prevailing business practices for sponsoring Expanded Access programs; and
- Capturing real-world evidence and the differentiating factors of treatment response.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Jess Rabourn, Founder, WideTrial
Recorded on: Oct. 19, 2017
Description: Regulatory expert Dan O’Leary untangles the web of regulations for IVDs. He discusses:
- Technical and practical definitions of various types of IVDs;
- The distinction between “finished devices,” “investigational products,” and “research products;”
- Premarket submission paths; and
- Labeling requirements.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Dan O’Leary, President, Ombu Enterprises LLC
Recorded on: Oct. 12, 2017
Description: A panel of experts discusses the outlook for devicemakers under FDA Commissioner Scott Gottlieb. They cover:
- New guidance documents aimed at medical devicemakers;
- Gottlieb’s big-picture approach to device regulation;
- What role patients will play in device development and approval; and
- How the FDA will sort out knotty issues surrounding combination products.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Wayne Pines, President, Health Care, APCO Worldwide; Marc Scheineson, Partner, Alston & Bird LLP; Mahnu Davar, Partner, Arnold & Porter/Kaye Scholer
Recorded on: Oct. 5, 2017
Description: Quality systems experts Tom Middleton and Mike Edwards discuss quality management factors that lead to success. They cover:
- Why the life sciences industry must emphasize quality over mere compliance;
- Current and emerging guidelines and regulations aimed at improving medical device and pharmaceutical product quality; and
- The challenges posed to mid-sized and emerging life sciences manufacturers.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Tom Middleton, Solutions Architect, and Mike Edwards, Senior Product Manager, Sparta Systems
Recorded on: Sept. 28, 2017
Description: A panel of industry experts discuss the FDA’s view of 3D printing of medical devices. They cover:
- Training surgeons to use 3D-printed models;
- Applications of 3D printing across the product lifecycle;
- Hurdles companies have faced in implementing 3D printing operations; and
- Bio-printing models of human cells and organs for use in clinical trials.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Thomas Marchand, CEO, BIOMODEX; Jenny Chen, CEO, 3DHEALS; Stavros Stefanis, Leader, Deloitte's Product Development Practice; Jennifer Petrosky, Director of Life Sciences Industry Marketing, Dassault Systèmes; and Daniel Matlis, President, Axendia
Recorded on: Sept. 26, 2017
Description: Quality systems specialist Dan O’Leary explains statistical techniques mandated under the FDA’s Quality System Regulation (§820.250). He discusses:
- The difference between variables data and attributes data;
- The concept of process variability and its common metrics;
- Valid statistical techniques in the context of FDA’s QSR; and
- How to apply this information to your manufacturing processes.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Dan O’Leary, President, Ombu Enterprises LLC